Stocks · Health care · Pharmaceutical Preparations

CytomX Therapeutics, Inc.

CTMX Clue Score50
United States Fiscal year ends December CIK 0001501989 Results filed 5 Nov 2026

What the insiders did Net selling

By person

25 insiders · 164 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Third Rock Ventures LP entity
10% owner
—
$28.70M (2)
−$28.70M
85,509
$260.80K
−98.4%
Sean A. McCarthy
CEO
—
$8.58M (40) scheduled
−$8.58M
2,159,971
$6.59M
+104.8%
Canaan IX L.P.
Director
—
$3.42M (14)
−$3.42M
2,494,381
$7.61M
−36.8%
Timothy M Shannon
Director
—
$3.42M (14)
−$3.42M
3,244,829
$9.90M
−8.5%
Debanjan Ray
Chief Financial Officer
—
$1.98M (21) scheduled
−$1.98M
5,928
$18.08K
−73.0%
Frederick W Gluck
Director
—
$1.52M (8)
−$1.52M
289,154
$881.92K
−19.0%
Robert I Tepper
10% owner
—
$1.20M (3)
−$1.20M
4,349,864
$13.27M
−1.4%
Rachel Humphrey
Chief Medical Officer
—
$1.20M (2) scheduled
−$1.20M
30,234
$92.21K
—
William Michael Kavanaugh
CSO, Head Res.&Non-Clin. Dev.
—
$1.18M (1) scheduled
−$1.18M
81,332
$248.06K
+6.7%
Kevin P Starr
10% owner
—
$463.79K (1)
−$463.79K
5,201,767
$15.87M
−0.5%
II Robert C. Goeltz
Chief Financial Officer
—
$426.34K (2) scheduled
−$426.34K
32,756
$99.91K
+445.9%
Marcia Belvin
SVP, Chief Scientific Officer
—
$294.10K (7)
−$294.10K
300,760
$917.32K
+250.5%
Christopher Ogden
Chief Financial Officer
—
$179.97K (9)
−$179.97K
295,324
$900.74K
+1,431%
Yu-Waye Chu
Chief Medical Officer
—
$139.09K (2)
−$139.09K
189,446
$577.81K
—
Lloyd A Rowland
General Counsel
$92.97K (1)
$47.00K (7)
+$45.97K
120,594
$367.81K
+483.8%
Jeffrey B Landau
Chief Business Officer
—
$38.71K (6)
−$38.71K
119,056
$363.12K
+315.1%
Amy C. Peterson
EVP, Chief Development Officer
—
$19.04K (2)
−$19.04K
58,433
$178.22K
+1,466%
Carlos Campoy
Chief Financial Officer
—
$9.08K (2)
−$9.08K
38,224
$116.58K
—
Alison L. Hannah
Chief Medical Officer
—
$7.97K (1)
−$7.97K
31,898
$97.29K
—
Elaine Jones V
Director
$7.75K (1)
—
+$7.75K
5,142
$15.68K
+3,521%
Neil Exter
Director
—
— (2)
$0.00
11,199
$34.16K
0.0%
Bvf Partners L P/Il entity
See Explanation of Responses
—
—
—
358,450
$1.09M
0.0%
Alejandra Carvajal
Chief Legal Officer
—
—
—
100,000
$305.00K
—
Rachael Lester
Chief Business Officer
—
—
—
20,000
$61.00K
—
Robin Knifsend
Principal Accounting Officer
—
—
—
2,791
$8.51K
+185.1%

No percentages here. This company's share count has moved by a factor of 2.7 over the window, from 80,621,293 to 217,899,284 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.